Clinical implications of inflammation in young children

American Journal of Respiratory and Critical Care Medicine

Volumn 162, Issue 2 II, 2000, Pages

  Bush, A ^a   Tiddens, H ^a   Silverman, M ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; ERYTHROMYCIN; IBUPROFEN;

ASTHMA; BACTERIAL INFECTION; BRONCHUS HYPERREACTIVITY; CHRONIC LUNG DISEASE; CLINICAL FEATURE; CYSTIC FIBROSIS; DIAGNOSTIC IMAGING; EOSINOPHIL; HELPER CELL; HUMAN; IMMUNE RESPONSE; NEUTROPHIL; PATHOGENESIS; PEAK EXPIRATORY FLOW; PREMATURITY; PRIORITY JOURNAL; REVIEW;

EID: 0033872720     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.162.supplement_1.maic-3     Document Type: Review

References (50)

1. Management of asthma: A consensus statement
2. International consensus report on the diagnosis and management of asthma
3. How much asthma is really attributable to atopy?
4. Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma
5. Sputum analysis, bronchial hyperresponsiveness, and airway function in asthma: Results of a factor analysis
6. Inflammation and airway function in asthma: What you see is not necessarily what you get
7. Bronchoalveolar cell profiles in children with asthma, infantile wheeze, chronic cough, or cystic fibrosis
8. Bronchoalveolar lavage findings suggest two different forms of childhood asthma
9. Bronchial biopsy evidence for leukocyte infiltration and up-regulation of leukocyte endothelial adhesion molecules 6 hours after local allergen challenge of sensitized asthmatic airways
10. Effect of inhaled endotoxin on bronchial reactivity in normal and asthmatic subjects
11. Noneosinophilic corticosteroid unresponsive asthma
12. Contribution of 92 kD gelatinase/type IV collagenase in bronchial inflammation during status asthmaticus
13. Inhaled glucocorticoid therapy of childhood asthma is associated with reduced peripheral blood T cell activation and 'Th2-type' cytokine mRNA expression
14. Use of induced sputum to examine airway inflammation in childhood asthma
15. Exhaled nitric oxide measurements in normal and asthmatic children
16. Effect of inhaled steroids on airway hyperresponsiveness, sputum eosinophils, and exhaled nitric oxide levels in patients with asthma
17. Effects of long-term treatment with an inhaled steroid on growth and lung function in asthmatic children
18. Effects of discontinuing inhaled budesonide in patients with mild asthma
19. Cessation of long-term treatment with inhaled corticosteroid (budesonide) in children with asthma results in deterioration: The Dutch CNSLD Study Group
20. Early pulmonary inflammation in infants with cystic fibrosis
21. Increased DNA levels in bronchoalveolar lavage fluid obtained from infants with cystic fibrosis
22. Lower airway inflammation in infants and young children with cystic fibrosis
23. A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosis
24. Randomized controlled trial of inhaled corticosteroids (fluticasone propionate) in cystic fibrosis
25. Controlled trial of inhaled budesonide in patients with cystic fibrosis and chronic bronchopulmonary Pseudomonas aeruginosa infection
26. Effect of high-dose ibuprofen in patients with cystic fibrosis
27. Erythromycin modulates IL-8 expression in normal and inflamed human bronchial epithelial cells
28. Long-term azithromycin may improve lung function in children with cystic fibrosis
29. Improvement of survival in patients with diffuse panbronchilitis treated with low-dose erythromycin
30. Neutrophil apoptosis and clearance from neonatal lungs
31. Increase in interleukin-8 and soluble intercellular adhesion molecule-1 in bronchoalveolar lavage fluid from premature infants who develop chronic lung disease
32. Increase in the concentration of transforming growth factor beta-1 in bronchoalveolar lavage fluid before development of chronic lung disease of prematurity
33. Increase in interleukin (IL)-1-beta and IL-6 in bronchoalveolar lavage fluid obtained from infants with chronic lung disease of prematurity
34. Systematic review and meta-analysis of early postnatal dexamethasone for prevention of chronic lung disease
35. Randomized controlled study of early use of inhaled corticosteroid in preterm infants with respiratory distress syndrome
36. Trial of beclomethasone dipropionate by metered-dose inhaler in ventilator-dependent neonates less than 1500 grams
37. Efficacy of sequential early systemic and inhaled corticosteroid therapy in the prevention of chronic lung disease of prematurity
38. Early inhaled glucocorticoid therapy to prevent bronchopulmonary dysplasia
39. Chronic lung disease of prematurity - Prevention by inhaled steroids
40. Occupational asthma
41. Clinical control and histopathological outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment
42. Assessment of airway inflammation in children with acute asthma using induced sputum
43. Persistence of sputum eosinophilia in children with controlled asthma when compared with healthy children
44. Reduction in serum IL-5, ECP, and IL-2R in acute childhood asthma with corticosteroid therapy
45. Eosinophilic inflammation in the bronchial mucosa of children with bronchial asthma
46. Activity of abundant antimicrobials of the human airway
47. CFTR gene transfer reduces the binding of Pseudomonas aeruginosa to cystic fibrosis respiratory epithelium
48. Reduction in the adherence of Pseudomonas aeruginosa to native cystic fibrosis epithelium with anti-asialoGM1 antibody and neuraminidase inhibition
49. Pseudomonas aeruginosa internalization by human epithelial respiratory cells depends on cell differentiation, polarity, and junctional complex integrity
50. Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes